Company Filing History:
Years Active: 2023-2025
Title: Innovations of Derek A Wainwright
Introduction
Derek A Wainwright is a notable inventor based in Brookfield, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of proteolysis-targeting chimeric molecules (PROTACs). With a total of 2 patents, his work focuses on innovative solutions for protein degradation.
Latest Patents
Wainwright's latest patents involve the design of PROTACs that induce the degradation of the indoleamine 2,3-dioxygenase (IDO) protein. These chimeric molecules typically include a first targeting moiety that binds to IDO, linked via a bond or a linker to a second targeting moiety that binds to an E3 ubiquitin ligase. The disclosed PROTACs can be described by the formula M-L-M or M-L-M, showcasing their innovative approach to targeted protein degradation.
Career Highlights
Derek A Wainwright is affiliated with Northwestern University, where he continues to advance research in his field. His work has garnered attention for its potential applications in therapeutic interventions, particularly in cancer treatment and other diseases where IDO plays a critical role.
Collaborations
Wainwright collaborates with Gary E Schiltz, further enhancing the research and development of their innovative projects. Their partnership exemplifies the importance of teamwork in scientific advancements.
Conclusion
Derek A Wainwright's contributions to the field of biochemistry through his innovative patents and collaborations highlight the significance of targeted therapies in modern medicine. His work continues to pave the way for future advancements in protein degradation technologies.